Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, o...

Por Godeaux, Olivier, Kovac, Martina, Shu, Daniel, Grupping, Katrijn, Campora, Laura, Douha, Martine, Heineman, Thomas C., Lal, Himal
Publicado no Hum Vaccin Immunother (2017)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matc...

Por Grupping, Katrijn, Campora, Laura, Douha, Martine, Heineman, Thomas C, Klein, Nicola P, Lal, Himal, Peterson, James, Oostvogels, Lidia
Publicado no Open Forum Infect Dis (2017)

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine

Por Grupping, Katrijn, Campora, Laura, Douha, Martine, Heineman, Thomas C, Klein, Nicola P, Lal, Himal, Peterson, James, Vastiau, Ilse, Oostvogels, Lidia
Publicado no J Infect Dis (2017)

Results of a Safety Pooled Analysis of an Adjuvanted Herpes Zoster Subunit Vaccine in More than 14,500 Participants Aged 50 Years or Older

Por López-Fauqued, Marta, Campora, Laura, Delannois, Frédérique, El Idrissi, Mohamed, Ledent, Edouard, Diez-Domingo, Javier, McElhaney, Janet, McNeil, Shelly, De Looze, Ferdinandus, Yeo, Wilfred, Silva, Fernanda Tavares Da
Publicado no Open Forum Infect Dis (2017)